A Phase 3 Extension Study of Ianalumab in Systemic Lupus Erythematosus

Study Description

A Study to Evaluate the Long-Term Safety of Ianalumab in Patients with Systemic Lupus Erythematosus

Study Details

Registry ID:

NCT06133972

Conditions:

Systemic Lupus Erythematosus

Phase:

Phase 3

Target Enrollment:

550 participants

Start Date:

May 21, 2024

Healthy Volunteers:

No

Study Locations (169 sites)

• Novartis Investigative Site
  Chuo Ku, TokyoJapan, Japan
• Novartis Investigative Site
  Santiago Compostela, A CorunaSpain, Spain
• Novartis Investigative Site
  Pretoria, GautengSouth Africa, South Africa
• Novartis Investigative Site
  Elche, AlicanteSpain, Spain
• Novartis Investigative Site
  Cape Town, Western CapeSouth Africa, South Africa
• Novartis Investigative Site
  Stellenbosch, Western CapeSouth Africa, South Africa
• Novartis Investigative Site
  Somerset West, Western CapeSouth Africa, South Africa
• Novartis Investigative Site
  ValenciaSpain, Spain
• Novartis Investigative Site
  LisbonPortugal, Portugal
• Novartis Investigative Site
  MadridSpain, Spain
• Novartis Investigative Site
  Salvador, Estado de BahiaBrazil, Brazil
• Novartis Investigative Site
  SalvadorBrazil, Brazil
• Novartis Investigative Site
  Salvador, BABrazil, Brazil
• Novartis Investigative Site
  San Sebastian Reyes, MadridSpain, Spain
• Novartis Investigative Site
  Barcelona, CatalunyaSpain, Spain
• Novartis Investigative Site
  Barcelona, CataloniaSpain, Spain
• Novartis Investigative Site
  BarcelonaSpain, Spain
• Novartis Investigative Site
  Badalona, CatalunyaSpain, Spain
• Novartis Investigative Site
  Badalona, CataloniaSpain, Spain
• Novartis Investigative Site
  Badalona, BarcelonaSpain, Spain
• Novartis Investigative Site
  BragaPortugal, Portugal
• Novartis Investigative Site
  UmhlangaSouth Africa, South Africa
• Novartis Investigative Site
  ToulouseFrance, France
• Novartis Investigative Site
  Santander, CantabriaSpain, Spain
• Novartis Investigative Site
  Santiago De Compostela, GaliciaSpain, Spain
• Novartis Investigative Site
  MontpellierFrance, France
• Novartis Investigative Site
  Montpellier 5France, France
• Novartis Investigative Site
  Pisa, PIItaly, Italy
• Novartis Investigative Site
  Torino, TOItaly, Italy
• Novartis Investigative Site
  Ramat GanIsrael, Israel
• Novartis Investigative Site
  HaifaIsrael, Israel
• Novartis Investigative Site
  Belo Horizonte, MGBrazil, Brazil
• Novartis Investigative Site
  Belo Horizonte, Minas GeraisBrazil, Brazil
• Novartis Investigative Site
  SofiaBulgaria, Bulgaria
• Novartis Investigative Site
  Niterói, Rio de JaneiroBrazil, Brazil
• Novartis Investigative Site
  Plovdiv, BulgariaBulgaria, Bulgaria
• Novartis Investigative Site
  Rio de Janeiro, Rio de JaneiroBrazil, Brazil
• Novartis Investigative Site
  PlovdivBulgaria, Bulgaria
• Novartis Investigative Site
  ParisFrance, France
• Novartis Investigative Site
  ZalaegerszegHungary, Hungary
• Novartis Investigative Site
  Szekesfehervar, FejerHungary, Hungary
• Novartis Investigative Site
  GyulaHungary, Hungary
• Novartis Investigative Site
  BucharestRomania, Romania
• Novartis Investigative Site
  BrnoCzechia, Czechia
• Novartis Investigative Site
  Uherske HradisteCzechia, Czechia
• Novartis Investigative Site
  PragueCzechia, Czechia
• Novartis Investigative Site
  Sao Paulo, SPBrazil, Brazil
• Novartis Investigative Site
  São Paulo, São PauloBrazil, Brazil
• Novartis Investigative Site
  BrasovRomania, Romania
• Novartis Investigative Site
  Cluj NapocaRomania, Romania
• Novartis Investigative Site
  Cluj-NapocaRomania, Romania
• Novartis Investigative Site
  Cluj-Napoca, ClujRomania, Romania
• Novartis Investigative Site
  Barretos, Sao PauloBrazil, Brazil
• Novartis Investigative Site
  Leipzig, SachsenGermany, Germany
• Novartis Investigative Site
  Leipzig, SaxonyGermany, Germany
• Novartis Investigative Site
  LeipzigGermany, Germany
• Novartis Investigative Site
  KošiceSlovakia, Slovakia
• Novartis Investigative Site
  BytomPoland, Poland
• Novartis Investigative Site
  Wroclaw, DolnoslaskiePoland, Poland
• Novartis Investigative Site
  Wroclaw, Lower Silesian VoivodeshipPoland, Poland
• Novartis Investigative Site
  BydgoszczPoland, Poland
• Novartis Investigative Site
  WarszawaPoland, Poland
• Novartis Investigative Site
  WarsawPoland, Poland
• Novartis Investigative Site
  La Plata, Buenos AiresArgentina, Argentina
• Novartis Investigative Site
  Quilmes, Buenos AiresArgentina, Argentina
• Novartis Investigative Site
  Ciudad Autonoma de Bs As, Buenos AiresArgentina, Argentina
• Novartis Investigative Site
  Buenos AiresArgentina, Argentina
• Novartis Investigative Site
  San Miguel, Buenos AiresArgentina, Argentina
• Novartis Investigative Site
  San Miguel, Tucumán ProvinceArgentina, Argentina
• Novartis Investigative Site
  San Miguel de TucumánArgentina, Argentina
• Novartis Investigative Site
  San Miguel de Tucuman, TucumanArgentina, Argentina
• Novartis Investigative Site
  TucumanArgentina, Argentina
• Novartis Investigative Site
  Bucaramanga, Santander DepartmentColombia, Colombia
• Novartis Investigative Site
  Bucaramanga, SantanderColombia, Colombia
• Novartis Investigative Site
  Chia, CundinamarcaColombia, Colombia
• Novartis Investigative Site
  BogotaColombia, Colombia
• Novartis Investigative Site
  BarranquillaColombia, Colombia
• Novartis Investigative Site
  Barranquilla, AtlanticoColombia, Colombia
• Novartis Investigative Site
  Medellin, AntioquiaColombia, Colombia
• Novartis Investigative Site
  Kolhāpur, MaharashtraIndia, India
• Novartis Investigative Site
  Pune, MaharashtraIndia, India
• Novartis Investigative Site
  Ahmedabad, GujaratIndia, India
• Novartis Investigative Site
  Nashik, MaharashtraIndia, India
• Novartis Investigative Site
  Cali, Valle del Cauca DepartmentColombia, Colombia
• Novartis Investigative Site
  Kozhikode, KeralaIndia, India
• Novartis Investigative Site
  SantiagoChile, Chile
• Novartis Investigative Site
  Santiago, Santiago MetropolitanChile, Chile
• Novartis Investigative Site
  Santiago, RMChile, Chile
• Novartis Investigative Site
  Nagpur, MaharashtraIndia, India
• Novartis Investigative Site
  New DelhiIndia, India
• Novartis Investigative Site
  New Delhi, New DelhiIndia, India
• Novartis Investigative Site
  Valdivia, Los Ríos RegionChile, Chile
• Novartis Investigative Site
  Rimouski, QuebecCanada, Canada
• IRIS Research and Development
  Plantation, FloridaUnited States, United States
• GNP Research
  Cooper City, FloridaUnited States, United States
• University Of Maryland Med Ctr
  Baltimore, MarylandUnited States, United States
• University Of Maryland
  Baltimore, MarylandUnited States, United States
• Clinical Research of West Florida Inc
  Tampa, FloridaUnited States, United States
• Clinical Res. of W Florida
  Clearwater, FloridaUnited States, United States
• Clinical Res Of W Florida
  Clearwater, FloridaUnited States, United States
• Parris and Associates Rheumatology
  Lawrenceville, GeorgiaUnited States, United States
• Paramount Med Rsrch and Consult LLC
  Middleburg Heights, OhioUnited States, United States
• Novartis Investigative Site
  Guatemala CityGuatemala, Guatemala
• Novartis Investigative Site
  GuatemalaGuatemala, Guatemala
• Novartis Investigative Site
  Guatemala City, Departamento de GuatemalaGuatemala, Guatemala
• Novartis Investigative Site
  Merida, YucatanMexico, Mexico
• Pinnacle Research Group Llc .
  Anniston, AlabamaUnited States, United States
• Pinnacle Research Group Llc
  Anniston, AlabamaUnited States, United States
• Henry Ford Health
  Detroit, MichiganUnited States, United States
• Ahmed Arif Medical Research Center
  Grand Blanc, MichiganUnited States, United States
• West Tennessee Research Institute
  Jackson, TennesseeUnited States, United States
• Shelby Research LLC
  Memphis, TennesseeUnited States, United States
• Robert A Hozman MD SC
  Skokie, IllinoisUnited States, United States
• Willow Rheumatology Wellness
  Willowbrook, IllinoisUnited States, United States
• Novartis Investigative Site
  Urumqi, XinjiangChina, China
• Accurate Clinical Research
  Lake Charles, LouisianaUnited States, United States
• Accurate Clinical Research
  League City, TexasUnited States, United States
• Novartis Investigative Site
  Ciudad de Mexico, Distrito FederalMexico, Mexico
• Novartis Investigative Site
  Mexico City, Mexico CityMexico, Mexico
• Novartis Investigative Site
  Ipoh, PerakMalaysia, Malaysia
• Novartis Investigative Site
  BangkokThailand, Thailand
• Epic Medical Research
  Red Oak, TexasUnited States, United States
• Novartis Investigative Site
  Morelia, MichoacánMexico, Mexico
• Novartis Investigative Site
  Leon, GuanajuatoMexico, Mexico
• Novartis Investigative Site
  Guadalajara, JaliscoMexico, Mexico
• Novartis Investigative Site
  Chengdu, SichuanChina, China
• Novartis Investigative Site
  ZhejiangChina, China
• University of Colorado Denver
  Aurora, ColoradoUnited States, United States
• Novartis Investigative Site
  MexicoMexico, Mexico
• Novartis Investigative Site
  Guangzhou, GuangdongChina, China
• Novartis Investigative Site
  Pingxiang, JiangxiChina, China
• Novartis Investigative Site
  Shantou, GuangdongChina, China
• Novartis Investigative Site
  XinxiangChina, China
• Novartis Investigative Site
  Nanchang, JiangxiChina, China
• Novartis Investigative Site
  KaohsiungTaiwan, Taiwan
• Novartis Investigative Site
  Kaohsiung CityTaiwan, Taiwan
• Advanced Medical Research
  La Palma, CaliforniaUnited States, United States
• Novartis Investigative Site
  Nanjing, JiangsuChina, China
• Novartis Investigative Site
  BeijingChina, China
• Novartis Investigative Site
  TaichungTaiwan, Taiwan
• Providence Medical Center
  Burbank, CaliforniaUnited States, United States
• Novartis Investigative Site
  Linyi, ShandongChina, China
• Millennium Clinical Trials
  Westlake Village, CaliforniaUnited States, United States
• Novartis Investigative Site
  TaoyuanTaiwan, Taiwan
• Novartis Investigative Site
  Taoyuan DistrictTaiwan, Taiwan
• Novartis Investigative Site
  TaipeiTaiwan, Taiwan
• Novartis Investigative Site
  Suzhou, JiangsuChina, China
• Novartis Investigative Site
  Ningbo, ZhejiangChina, China
• Novartis Investigative Site
  ShanghaiChina, China
• Novartis Investigative Site
  Gwangju Gwangyeoksi, GwangjuSouth Korea, South Korea
• Novartis Investigative Site
  GwangjuSouth Korea, South Korea
• Novartis Investigative Site
  Gwangju GwangyeoksiSouth Korea, South Korea
• Novartis Investigative Site
  Seoul, Seocho GuKorea, Republic of, Korea, Republic of
• Novartis Investigative Site
  SeoulKorea, Republic of, Korea, Republic of
• Novartis Investigative Site
  Seoul, Seocho GuSouth Korea, South Korea
• Novartis Investigative Site
  SeoulSouth Korea, South Korea
• Novartis Investigative Site
  Vancouver, British ColumbiaCanada, Canada
• Novartis Investigative Site
  Changchun, JilinChina, China
• Novartis Investigative Site
  Chang Chun, JilinChina, China
• Novartis Investigative Site
  Nagoya, AichiJapan, Japan
• Novartis Investigative Site
  Nagoya, Aichi-kenJapan, Japan
• Novartis Investigative Site
  Fuchū, TokyoJapan, Japan
• Novartis Investigative Site
  Yokohama, Kanagawa-kuJapan, Japan
• Novartis Investigative Site
  Yokohama, KanagawaJapan, Japan
• Novartis Investigative Site
  Shinjuku-kuJapan, Japan
• Novartis Investigative Site
  Bunkyo-kuJapan, Japan
• Novartis Investigative Site
  Sapporo city, HokkaidoJapan, Japan
• Novartis Investigative Site
  Sapporo, HokkaidoJapan, Japan
• Novartis Investigative Site
  Maroochydore, QueenslandAustralia, Australia

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →